Evolving roles of activins and inhibins in ovarian cancer pathophysiology

Am J Physiol Cell Physiol. 2023 Feb 1;324(2):C428-C437. doi: 10.1152/ajpcell.00178.2022. Epub 2023 Jan 9.

Abstract

Activins and inhibins are unique members of the transforming growth factor-β (TGFβ) family of growth factors, with the ability to exert autocrine, endocrine, and paracrine effects in a wide range of complex physiologic and pathologic processes. Although first isolated within the pituitary, emerging evidence suggests broader influence beyond reproductive development and function. Known roles of activin and inhibin in angiogenesis and immunity along with correlations between gene expression and cancer prognosis suggest potential roles in tumorigenesis. Here, we present a review of the current understanding of the biological role of activins and inhibins as it relates to ovarian cancers, summarizing the underlying signaling mechanisms and physiologic influence, followed by detailing their roles in cancer progression, diagnosis, and treatment.

Keywords: TGFβ superfamily; activin; inhibin; ovarian cancer; tumor immune environment.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Activins / genetics
  • Activins / metabolism
  • Endocrine System / metabolism
  • Female
  • Humans
  • Inhibins* / genetics
  • Inhibins* / metabolism
  • Ovarian Neoplasms* / genetics
  • Signal Transduction

Substances

  • Inhibins
  • Activins